lifibrol has been researched along with Hyperlipidemias in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bell, FP | 1 |
Friedrich, I; Klima, B; Köster, W; März, W; Nuber, C; Sattler, A; Schäfer, JR; Steinmetz, A; Wieland, H; Winkler, K | 1 |
1 trial(s) available for lifibrol and Hyperlipidemias
Article | Year |
---|---|
Lifibrol enhances the low density lipoprotein apolipoprotein B-100 turnover in patients with hypercholesterolemia and mixed hyperlipidemia.
Topics: Adult; Anticholesteremic Agents; Apolipoproteins B; Butanols; Female; Gas Chromatography-Mass Spectrometry; Humans; Hydroxybenzoates; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Male; Middle Aged; Statistics, Nonparametric; Treatment Outcome | 1999 |
1 other study(ies) available for lifibrol and Hyperlipidemias
Article | Year |
---|---|
Effect of the lipid-lowering drug lifibrol on lipid metabolism in rat macrophages and in atherosclerotic arteries from swine and WHHL rabbits, in vitro. Implications in atherogenesis.
Topics: Acetates; Animals; Aorta; Arteries; Arteriosclerosis; Butanols; Carbon Radioisotopes; Cholesterol; Hydroxybenzoates; Hyperlipidemias; Hypolipidemic Agents; Lipids; Macrophages, Peritoneal; Male; Oleic Acid; Oleic Acids; Rabbits; Rats; Rats, Sprague-Dawley; Swine | 1993 |